|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 875.00 INR | +0.60% |
|
+1.65% | +21.55% |
| Capitalization | 661B 7.28B 6.19B 5.79B 5.44B 10.03B 10.95B 67.55B 26.11B 311B 27.32B 26.75B 1,131B | P/E ratio 2026 * |
57.9x | P/E ratio 2027 * | 44.5x |
|---|---|---|---|---|---|
| Enterprise value | 677B 7.46B 6.34B 5.94B 5.57B 10.27B 11.22B 69.2B 26.75B 319B 27.99B 27.4B 1,158B | EV / Sales 2026 * |
7.33x | EV / Sales 2027 * | 6.17x |
| Free-Float |
64.76% | Yield 2026 * |
0.15% | Yield 2027 * | 0.18% |
Last Transcript: Fortis Healthcare Limited
| 1 day | +0.60% | ||
| 1 week | +1.65% | ||
| Current month | -4.80% | ||
| 1 month | -6.69% | ||
| 3 months | -10.50% | ||
| 6 months | +16.05% | ||
| Current year | +21.55% |
| 1 week | 848.95 |  | 882 |
| 1 month | 845.4 | | 953.2 |
| Current year | 577 | | 1,104.3 |
| 1 year | 577 | | 1,104.3 |
| 3 years | 245.5 | | 1,104.3 |
| 5 years | 148.05 | | 1,104.3 |
| 10 years | 107.1 | | 1,104.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 2019-03-18 | |
| Director of Finance/CFO | - | 2019-04-07 | |
Daljit Singh
PSD | President | 72 | 2002-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 59 | 2018-04-26 | |
| Chairman | 69 | 2024-09-30 | |
| Director/Board Member | 63 | 2019-03-18 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0.02% | 51 M€ | +4.72% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.60% | +1.65% | +22.90% | +207.67% | 7.24B | |
| +0.23% | +2.47% | +21.62% | +47.80% | 18.78B | |
| -0.63% | -3.77% | -23.82% | -52.14% | 14.56B | |
| -0.49% | -0.63% | -2.86% | +51.88% | 11.23B | |
| +0.14% | -0.35% | +10.18% | +86.76% | 10.83B | |
| -1.99% | +4.23% | -19.59% | -30.27% | 10.15B | |
| -0.46% | +0.86% | +23.37% | +83.58% | 10.19B | |
| -0.37% | -0.37% | -22.16% | - | 8.11B | |
| -1.27% | -2.24% | -5.45% | -46.44% | 5.4B | |
| -0.38% | -1.65% | +47.01% | +151.58% | 4.25B | |
| Average | -0.46% | -0.17% | +5.12% | +55.60% | 10.07B | |
| Weighted average by Cap. | -0.41% | -0.02% | +3.31% | +44.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 92.32B 1.02B 865M 810M 760M 1.4B 1.53B 9.44B 3.65B 43.45B 3.82B 3.74B 158B | 108B 1.19B 1.01B 949M 891M 1.64B 1.79B 11.07B 4.28B 50.94B 4.48B 4.38B 185B |
| Net income | 11.46B 126M 107M 101M 94.39M 174M 190M 1.17B 453M 5.39B 474M 464M 19.61B | 14.82B 163M 139M 130M 122M 225M 246M 1.52B 586M 6.98B 613M 600M 25.37B |
| Net Debt | 16.08B 177M 151M 141M 132M 244M 267M 1.64B 636M 7.57B 665M 651M 27.53B | 7.42B 81.83M 69.58M 65.11M 61.15M 113M 123M 759M 293M 3.49B 307M 301M 12.71B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-16 | 875.00 ₹ | +0.60% | 2,131,839 |
| 25-12-15 | 869.80 ₹ | -0.49% | 834,186 |
| 25-12-12 | 874.05 ₹ | +2.13% | 2,286,632 |
| 25-12-11 | 855.85 ₹ | +0.34% | 1,367,549 |
| 25-12-10 | 852.95 ₹ | -1.26% | 3,041,856 |
Delayed Quote NSE India S.E., December 16, 2025 at 06:49 am EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- FORTIS Stock
Select your edition
All financial news and data tailored to specific country editions
